WB
Staurosporine treated and untreated A2780 cells were subjected to SDS PAGE followed by western blot with Cleaved PARP1 antibody at dilution of 1:20000 incubated at room temperature for 1.5 hours. The membrane was stripped and re-blotted with HRP-conjugated Lamin B1 antibody as a loading control.
IHC
Immunohistochemical analysis of paraffin-embedded Jurkat (left) and Staurosporine treated Jurkat (right) cells slide using Cleaved PARP1 antibody at dilution of 1:2000 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).
ICC/IF
Immunofluorescent analysis of (4% PFA) fixed untreated and 1 μM Staurosporine (3 hours) treated HSC-T6 cells using Cleaved PARP1 antibody at dilution of 1:1000 and 594-Goat Anti-Mouse Recombinant Secondary Antibody (H+L).
WB
a Western blot analysis of Cleaved-Caspase3 and Cleaved-PARP protein expression, and both of them were enhanced following TNF-α treatment. GAPDH was used as a loading control.
WB
a Western blot analysis of Cleaved-Caspase3 and Cleaved-PARP protein expression indicated that apoptosis was significantly inhibited by knocking down TIPE2. GAPDH was used as a loading control.